Death simulation + Ketamine
Ketamine is known to produce death simulation, a transpersonal effect. Profound subjective experience of dying, including life review, acceptance, and dissolution, distinct from ego death in its specific simulation of the death process.
About Death simulation
Death simulation (also called the dying experience, practice death, or ego death with thanatological features) refers to a profound psychedelic or dissociative experience in which the individual subjectively undergoes what they interpret as the process of their own death. This goes beyond the general dissolution of self-identity characteristic of ego death to include specific phenomenological features associated with dying: a sense of physical systems shutting down, life review (rapid replaying of significant life memories), acceptance or surrender, passage through darkness or void, and sometimes encounters with deceased loved ones or transcendent realms.
The experience bears striking resemblance to the near-death experiences (NDEs) reported by individuals who have been clinically close to death and revived. Both phenomena share core features identified by NDE researchers: a sense of leaving the body, moving through a tunnel or void, encountering a light or presence, experiencing a life review, reaching a boundary or point of no return, and returning to the body with a sense of having been given a second chance. The similarity is so pronounced that some researchers have proposed that psychedelic death simulation and NDEs share common neural mechanisms.
5-MeO-DMT is the substance most strongly associated with death simulation. The overwhelming intensity of the 5-MeO-DMT experience, particularly when smoked or insufflated, produces such rapid and complete dissolution of normal consciousness that the brain may interpret the experience through its neural templates for death -- the same circuits that would activate during actual physiological dying. Users frequently describe the experience in explicitly thanatological terms: "I died," "I went through death and came back," "I experienced my own funeral."
High-dose psilocybin and LSD can produce death simulation, particularly when the dose is sufficient to produce complete ego dissolution. The psychedelic life review -- a rapid, emotionally vivid replaying of significant autobiographical memories -- is one of the most commonly reported features and appears to involve hyperactivation of autobiographical memory networks in the hippocampus and medial temporal lobe.
Ketamine at anesthetic doses produces death simulation through a distinct mechanism: complete dissociation from bodily awareness combined with the "K-hole" experience of traversing void spaces and encountering seemingly transcendent realities. John Lilly's famous explorations of ketamine explicitly framed the experience in terms of death and rebirth.
The psychological impact of death simulation is often transformative. Research on NDEs has consistently found that individuals who undergo the experience report lasting reductions in death anxiety, increased appreciation for life, enhanced sense of meaning, and shifts in values toward compassion and connection. Psychedelic death simulation appears to produce similar outcomes. In psilocybin therapy for existential distress in terminal cancer patients, the occurrence of death-themed mystical experiences was strongly correlated with lasting reductions in anxiety and depression.
However, death simulation can be terrifying when unexpected or resisted. The individual who does not understand what is happening may believe they are actually dying, which can produce extreme panic, dangerous behavior, and lasting psychological trauma. Adequate preparation, a safe setting, and experienced guides who can reassure the individual during the experience are essential safety considerations.